Skip to content

Here’s How KFTD Performs Risk Assessment for Anti-Bribery System

As an esteemed company in the field of pharmaceutical and medical supply chain, Kimia Farma Trading & Distribution (KFTD) constantly commits to building healthy business practices and encouraging good corporate governance. KFTD integrity is proven through the implementation of an anti-bribery  system which follows the standardization of ISO 37001:2016 certificates. 

A Brief Introduction of KFTD’s Anti-Bribery System

In line with implementing the principles of good corporate governance, KFTD implements a system consisting of organizational structures, activities, resources, and procedures to prevent Bribery and Corruption issues in KFTD, namely, the Anti-Bribery Management System.

The system is applied with the aim of developing and instigating the anti-bribery policy in KFTD . To achieve such goals, KFTD needs to carry out several preparatory procedures, including composing the system guide, analyzing supporting documents, and performing risk assessment.  

Risk Assessment Procedures in the Anti-Bribery System

KFTD Bribery Risk Assessment is a process of identifying, assessing, and evaluating any potential risk of bribery practices within the company. Such a process aims to reduce the significant effects of the aforementioned risks. The process serves as the last step in the implementation of an anti-bribery system. 

Moreover, risk assessment is also important to prevent and tackle the practices of bribery and corruption, particularly in KFTD. This is because the process involves a set of procedures that address corruption issues as well. The procedures of anti-bribery risk assessment are carried out through the following steps:

  1. Identifying the risks of bribery practices.
  2. Analyzing the causes of bribery risks.
  3. Assessing the level of risks to prioritize its significance.
  4. Organizing mitigation and its responsible authority, as well as determining the deadline of mitigation to reduce the risks of bribery. 
  5. Evaluating the suitability and effectiveness  of mitigation procedures.
  6. Periodically monitor and evaluate the risk management of bribery practices based on the structural reports from each company unit. 

Taking such procedures into account, KFTD has proven itself to be a company that successfully adheres to the principles of good corporate governance. Therefore, its vision of becoming a renowned pharmaceutical and medical supply distribution company can be achieved.